Amrutanjan Health Care: Should You Buy, Hold, or Sell Right Now?
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
Amrutanjan Health Care share price Rs 496.85 (NSE), near its 52-week low. 52-week range Rs 482.65 to Rs 790.95. Trades at a discount of 27.12 times earnings.
Quick Answer
Amrutanjan Health Care Ltd share price is trading around Rs 497, close to its 52-week low of Rs 482.65 and more than 37 percent below its 52-week high of Rs 790.95. This consumer healthcare company, known for its Amrutanjan balm, trades at a price to earnings ratio of 27.12, a discount to the pharma and consumer healthcare sector average near 50.8 times, with a return on equity of 17.42 percent and a debt-free balance sheet. Current-quarter financial data was not consistently available across public sources at the time of writing, so this article relies on the most recently available trailing metrics and flags the stock’s sharp decline from its 52-week high as worth investigating further.
Amrutanjan Health Care share price has fallen more than 37 percent from its 52-week high of Rs 790.95, with Amrutanjan Health Care share price now trading near Rs 497 on the NSE, close to its 52-week low of Rs 482.65. Given the sharp decline alongside limited current-quarter data, this article presents the available valuation picture plainly before laying out a balanced view.
This Amrutanjan Health Care overview walks through the available valuation data, the sharp decline from the 52-week high, shareholding pattern and the technical setup, using figures sourced from public filings, with appropriate caveats given the data limitations involved.
Click Here – Get Free Investment Predictions
About Amrutanjan Health Care
Before deciding on Amrutanjan Health Care share price, it helps to understand the underlying business. Amrutanjan Health Care Ltd. manufactures consumer healthcare products, best known for its Amrutanjan balm brand, alongside a range of pain relief and healthcare products serving the Indian market.
As a consumer healthcare brand, Amrutanjan Health Care has maintained a debt-free balance sheet, and current-quarter financial data was not consistently available across public sources at the time of writing, meaning investors should seek the company’s latest exchange filings directly for more current information before making any decision.
Amrutanjan Health Care Share Price Today: Key Levels
The table below summarises where Amrutanjan Health Care share price stands right now against its recent trading range and market value.
| Metric | Value |
|---|---|
| Amrutanjan Health Care CMP (NSE) | Rs 496.85 |
| Amrutanjan Health Care CMP (BSE) | Rs 497.25 |
| 52-Week High | Rs 790.95 |
| 52-Week Low | Rs 482.65 |
| Market Capitalisation | Approximately Rs 1,464 crore |
| Dividend Yield | 0.97% |
Amrutanjan Health Care share price is trading close to its 52-week low, having fallen sharply from its 52-week high, reflecting a significant decline in market sentiment over the past year.
Check the Univest Screener for Live Stock Data
Amrutanjan Health Care Financial Performance
The Amrutanjan Health Care share price trend is closely tied to how these numbers evolve each quarter. Current-quarter financial data for Amrutanjan Health Care was not consistently available across public sources at the time of writing. The company’s trailing twelve-month figures show a positive EPS of Rs 18.67 and a return on equity of 17.42 percent, indicating the business is currently generating a solid return.
Investors should refer directly to the company’s latest exchange filings for updated quarterly figures before drawing conclusions about the reasons behind the stock’s sharp recent decline, given the limited publicly available recent data.
| Period | Revenue | Net Profit | Comment |
|---|---|---|---|
| Trailing twelve months | Not fully disclosed publicly | EPS Rs 18.67, ROE 17.42% | Current-quarter data not consistently available |
Valuation Check: Is Amrutanjan Health Care Share Price Expensive?
Any view on Amrutanjan Health Care share price should start from these valuation multiples. Amrutanjan Health Care share price currently reflects a price to earnings ratio of about 27.12 times trailing earnings, a discount to the broader consumer healthcare sector average of roughly 50.8 times. The price to book ratio stands near 4.0 times, with a dividend yield of 0.97 percent.
Debt to equity of 0.00 means the company carries no debt. Given the stock’s sharp decline from its 52-week high without clearly available current-quarter data to explain it, investors should seek more current disclosure before drawing firm conclusions about the valuation.
Technical Signals: What the Chart Shows
Price action here often foreshadows the next move in Amrutanjan Health Care share price. Amrutanjan Health Care share price is currently positioned close to its 52-week low of Rs 482.65, more than 37 percent below its 52-week high of Rs 790.95, reflecting a significant decline in market sentiment over the past year. A stock trading here after such a sharp fall typically signals either a genuine deterioration in the underlying business or a broader consumer sector sentiment shift, and the limited current data makes it difficult to distinguish between the two.
Trading volumes remain moderate, so investors should track Amrutanjan Health Care share price alongside the company’s next confirmed quarterly disclosure to understand the reasons behind the decline, rather than relying on trailing valuation metrics alone at these technical levels.
Download the Univest iOS App or Univest Android App to track Amrutanjan Health Care’s live price and technical levels.
Shareholding Pattern
Shifts here can influence Amrutanjan Health Care share price more than headline news on some sessions. Amrutanjan Health Care is a promoter-led, debt-free consumer healthcare brand best known for its balm products. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company’s latest exchange filing.
Why Investors Are Watching Amrutanjan Health Care
- Debt-free balance sheet: A debt to equity ratio of 0.00 gives the company a very strong financial position.
- Discount valuation to sector: A 27.12x PE against a 50.8x consumer healthcare sector average offers some valuation cushion.
- Solid trailing return on equity: A 17.42 percent return on equity indicates the business has been generating solid returns on the most recently available data.
Risks and Factors to Watch
- Sharp decline from 52-week high without clear explanation: The stock has fallen more than 37 percent from its high, and current-quarter data was not consistently available to clarify the reasons behind this decline.
- Limited current-quarter data: Recent quarterly financial data was not consistently available across public sources at the time of writing, creating an information gap for investors.
- Consumer healthcare brand competitive pressure: Amrutanjan Health Care competes against other established consumer healthcare and pain relief brands.
- Seasonal and category demand sensitivity: As a balm and pain relief brand, demand can be sensitive to seasonal patterns and broader consumer healthcare spending trends.
Amrutanjan Health Care Share Price Target: What the Data Suggests
Until then, Amrutanjan Health Care share price remains best tracked through live, verified data rather than a single fixed number. Amrutanjan Health Care does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the limited current-quarter data available to explain the recent sharp decline.
Investors considering this stock should track the Univest Screener for the company’s next confirmed quarterly disclosure, and should consult a SEBI-registered investment adviser given the data limitations involved.
Amrutanjan Health Care: Should You Buy, Hold, or Sell Right Now?
This is the core question behind Amrutanjan Health Care share price right now. The Amrutanjan Health Care buy or sell decision should account for the limited current-quarter data and the sharp recent decline.
The case for buying: Value-focused investors who see the discount to sector PE and debt-free balance sheet as attractive, and who are comfortable proceeding without a clear explanation for the recent decline, may find the current level worth considering.
The case for holding: Existing shareholders who already track Amrutanjan Health Care’s brand business may prefer to stay invested.
The case for waiting: Investors wanting to understand the reasons behind the sharp decline before committing fresh capital may prefer to wait for the company’s next earnings disclosure.
Given the data limitations here, weigh this against your own risk tolerance and consult a SEBI-registered investment adviser if unsure.
Conclusion
Amrutanjan Health Care share price reflects a debt-free consumer healthcare brand trading close to its 52-week low after a sharp decline from its high, with limited current-quarter data available to explain the move. This article is for informational purposes and not a personalised investment recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Q1. Is Amrutanjan Health Care a good stock to buy right now?
Ans. Amrutanjan Health Care trades at a discount of 27.12 times earnings against a 50.8 times consumer healthcare sector average, with a solid trailing return on equity of 17.42 percent. Given the stock’s sharp decline from its 52-week high and limited current-quarter data, this suits value-focused investors comfortable proceeding cautiously.
Q2. What is the Amrutanjan Health Care share price today?
Ans. Amrutanjan Health Care share price is trading around Rs 497 on the NSE, close to its 52-week low of Rs 482.65. The stock’s 52-week high is Rs 790.95.
Q3. What is the Amrutanjan Health Care share price target?
Ans. Amrutanjan Health Care does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the limited current-quarter data available.
Q4. What brand does Amrutanjan Health Care make?
Ans. Amrutanjan Health Care manufactures consumer healthcare products, best known for its Amrutanjan balm brand, alongside a range of pain relief and healthcare products.
Q5. Why has Amrutanjan Health Care’s share price fallen so much?
Ans. Amrutanjan Health Care share price has fallen more than 37 percent from its 52-week high, though current-quarter financial data was not consistently available across public sources at the time of writing to clarify the specific reasons behind this decline.
Q6. Is Amrutanjan Health Care debt free?
Ans. Yes, Amrutanjan Health Care carries a debt to equity ratio of 0.00, reflecting a debt free balance sheet.